Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
69.32
+0.65 (0.95%)
Jul 22, 2026, 4:00 PM EDT - Market closed

Nektar Therapeutics Analyst Ratings

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Canaccord Genuity
Canaccord Genuity
Buy
Initiates
$153
BuyInitiates$153+120.72%Jul 22, 2026
BTIG
BTIG
Buy
Reiterates
$178
BuyReiterates$178+156.78%Jul 14, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$185
BuyReiterates$185+166.88%Jul 1, 2026
Citi
Citi
Buy
Maintains
$76$151
BuyMaintains$76$151+117.83%May 14, 2026
Wedbush
Wedbush
Hold
Maintains
$95$80
HoldMaintains$95$80+15.41%May 11, 2026
Oppenheimer
Oppenheimer
Buy
Maintains
$140
BuyMaintains$140+101.96%May 8, 2026
Piper Sandler
Piper Sandler
Buy
Maintains
$105$192
BuyMaintains$105$192+176.98%May 8, 2026
TD Cowen
TD Cowen
Buy
Reiterates
n/a
BuyReiteratesn/an/aMay 8, 2026

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

  • Investment ideas from the top Wall Street analysts
  • Unlimited access to all data and tools
  • Advanced analyst filtering and sorting options
  • Up to 3 years of analyst rating history
Sign Up Today

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate
The percentage of ratings that are profitable.
Average Return
The average percentage return within one year of the rating.
Rating Count
The more ratings the analyst has provided, the higher the score.
Recency
Ratings provided within the past year contribute to a higher score.